Standout Papers
- Understanding the tumor immune microenvironment (TIME) for effective therapy (2018)
- PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations (2016)
- Immunosuppressive networks in the tumour environment and their therapeutic relevance (2005)
- Regulatory T cells, tumour immunity and immunotherapy (2006)
- Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy (2017)
- Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy (2017)
- Inhibitory B7-family molecules in the tumour microenvironment (2008)
- Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy (2015)
- Cancer nanomedicine for combination cancer immunotherapy (2019)
- Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments (2009)
- T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment (2013)
- B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma (2006)
- Oxidative stress controls regulatory T cell apoptosis and suppressor activity and PD-L1-blockade resistance in tumor (2017)
- CD8+ T cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4 (2022)
- Tumor-Associated Macrophages Produce Interleukin 6 and Signal via STAT3 to Promote Expansion of Human Hepatocellular Carcinoma Stem Cells (2014)
- Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells (2001)
- Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade–mediated tumor regression (2018)
- Inactivation of CDK12 Delineates a Distinct Immunogenic Class of Advanced Prostate Cancer (2018)
- Autophagy in tumour immunity and therapy (2021)
- Ironing out the role of ferroptosis in immunity (2024)
Immediate Impact
15 by Nobel laureates 25 from Science/Nature 139 standout
Citing Papers
Immune checkpoint therapy—current perspectives and future directions
2023 StandoutNobel
Pancreatic cancer: Advances and challenges
2023 Standout
Works of Weiping Zou being referenced
Interleukin 22 Signaling Regulates Acinar Cell Plasticity to Promote Pancreatic Tumor Development in Mice
2019
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy
2017 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Weiping Zou | 19426 | 16526 | 10603 | 185 | 34.3k | |
| Yang‐Xin Fu | 22067 | 13857 | 9566 | 372 | 36.8k | |
| George Coukos | 16776 | 17255 | 12693 | 392 | 34.6k | |
| Dmitry I. Gabrilovich | 40807 | 25340 | 15291 | 261 | 55.9k | |
| Ton N. Schumacher | 22341 | 17479 | 9526 | 309 | 33.5k | |
| Thomas F. Gajewski | 20433 | 19392 | 11602 | 319 | 35.1k | |
| Oliver Kepp | 12412 | 10942 | 13946 | 274 | 33.2k | |
| Catherine Sautès‐Fridman | 15615 | 14429 | 8164 | 300 | 28.2k | |
| Ignacio Melero | 16403 | 15374 | 6438 | 384 | 27.3k | |
| Johanna A. Joyce | 10440 | 11468 | 11788 | 103 | 28.3k | |
| Robert H. Vonderheide | 13907 | 14819 | 6700 | 221 | 24.3k |
All Works
Login with ORCID to disown or claim papers
Loading papers...